As Pfizer Deal Speeds Up, Aurobindo Pairs Up With AstraZeneca For Branded Generics Play In Emerging Markets
This article was originally published in The Pink Sheet Daily
Executive Summary
India's Aurobindo Pharma is turning out to be a partner of choice for Big Pharma companies that intend to dig aggressively into emerging markets with a branded generics product portfolio.